Kfir Oved
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Bacterial Identification and Susceptibility Testing 8
- Co-authors
- Yoram Reiter (9 shared papers)Eran Eden (11 shared papers)Asi Cohen (6 shared papers)Roy Noy (6 shared papers)Tanya M. Gottlieb (7 shared papers)Roy Navon (7 shared papers)Olga Boico (6 shared papers)Adi Klein (5 shared papers)
- Journals
- PLoS ONE (4 papers)Open Forum Infectious Diseases (3 papers)Neurology (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)Future Microbiology (2 papers)
- Partner nations
- IsraelNetherlandsUnited States
In The Last Decade
Kfir Oved
34 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 94
- Applied Microbiology and Biotechnology 79
- Infectious Diseases 217
- Clinical Biochemistry 75
- Epidemiology 295
- Immunology 149
Countries citing papers authored by Kfir Oved
This map shows the geographic impact of Kfir Oved's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kfir Oved with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kfir Oved more than expected).
Fields of papers citing papers by Kfir Oved
This network shows the impact of papers produced by Kfir Oved. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kfir Oved. The network helps show where Kfir Oved may publish in the future.
Co-authors
The 25 scholars most cited alongside Kfir Oved, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 189 | |
| 2 | 2020 | 102 | |
| 3 | 2017 | 94 | |
| 4 | 2019 | 90 | |
| 5 | 2018 | 72 | |
| 6 | 2021 | 64 | |
| 7 | 2016 | 42 | |
| 8 | 2021 | 39 | |
| 9 | 2004 | 36 | |
| 10 | 2017 | 36 | |
| 11 | Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinoma. | 2009 | 35 |
| 12 | 2019 | 28 | |
| 13 | 2010 | 27 | |
| 14 | 2014 | 27 | |
| 15 | 2015 | 26 | |
| 16 | 2009 | 24 | |
| 17 | 2022 | 21 | |
| 18 | 2018 | 20 | |
| 19 | 2005 | 16 | |
| 20 | 2018 | 15 |
About Kfir Oved
Kfir Oved is a scholar working on Clinical Biochemistry, Infectious Diseases, Immunology, Applied Microbiology and Biotechnology and Epidemiology, having authored 37 papers that have together received 1.1k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (8 papers), Respiratory viral infections research (5 papers), Immunotherapy and Immune Responses (5 papers), T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (4 papers), Pneumonia and Respiratory Infections (4 papers) and Antibiotic Use and Resistance (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (79 citations), Infectious Diseases (217 citations), Clinical Biochemistry (75 citations), Epidemiology (295 citations) and Immunology (149 citations). Kfir Oved has collaborated with scholars based in Israel, Netherlands and United States. Frequent co-authors include Yoram Reiter, Eran Eden, Asi Cohen, Roy Noy, Tanya M. Gottlieb, Roy Navon, Olga Boico, Adi Klein, Isaac Srugo and Avital Lev. Their work appears in journals such as PLoS ONE, Open Forum Infectious Diseases, Neurology, European Journal of Clinical Microbiology & Infectious Diseases and Future Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.